Table 1.
Baseline characteristics of patients who underwent kidney biopsy and their baseline eosinophilia on hematology
| Demographics | No Eosinophilia ≤ 4% (n = 113) |
Peripheral Eosinophilia > 4% (n = 65) |
P-value |
|---|---|---|---|
| Female | 56 (50%) | 21 (32%) | 0.025 |
| Age, mean (SD), y | 51 (17) | 53 (18) | 0.51 |
| Race | |||
| White | 57 (50%) | 31 (48%) | 0.55 |
| Black | 47 (42%) | 30 (46%) | |
| Other | 9 (8%) | 4 (6%) | |
| Asthma | 17 (15%) | 8 (12%) | 0.61 |
| Filarial Disease | 0 (0%) | 1 (2%) | 0.19 |
| HIV | 15 (14%) | 4 (6%) | 0.13 |
| Transplant | 18 (16%) | 8 (13%) | 0.54 |
| HTN | 80 (71%) | 42 (70%) | 0.84 |
| Baseline eGFR stagea | |||
| I | 63 (56) | 49 (76) | 0.013 |
| II | 35 (31) | 9 (13) | |
| III | 10 (8) | 3 (5) | |
| IV | 1 (1) | 3 (5) | |
| early V | 4 (4) | 1 (1) | |
| Diabetes | 19 (17) | 15 (23) | 0.32 |
| Mean UPCR (SD), g | 3.4 (9.9) | 3.2 (4.5) | 0.86 |
| Mean serum Cr at biopsy (SD), mg/dl | 2.9 (2.9) | 3.9 (3.9) | 0.043 |
| Indication for kidney biopsy | |||
| AKI | 45 (40) | 23 (37) | 0.03 |
| CKD | 5 (4) | 0 (0) | |
| AKOCKD | 39 (27) | 35 (53) | |
| Nephrotic Syndrome | 24 (21) | 7 (10) | |
Results expressed as n (%), unless otherwise indicated
abased on eGFR by CKD-Epi equation
Abbreviations: HIV human immunodeficiency virus; HTN hypertension; eGFR estimated glomerular filtration rate; UPCR urine-protein-creatinine-ratio; Cr creatinine; AKI acute kidney injury; CKD chronic kidney disease; AOCKD acute on chronic kidney injury